TABLE 1.

Characteristics of the healthy food prescription studies included in the systematic review¹

Study	Country	Setting	Design	Medical inclusion criteria	Food insecurity criteria	n	Age,2 y	% Female	Follow-up (mo)	RoB3
Bihan (37)	France	Healthcare center	RCT	None	Yes	135	44.6 ± 8.1	56.3	3	Some concerns
Buyuktuncer (24)	UK	Primary care clinics	Pre/post	None	No	124	≥ 16	71.8	5	Serious
Weinstein (38)	USA	Primary care or diabetes clinics	RCT	Diabetes mellitus, BMI >25 kg/m2 and HbA1c >7%	No	79	55 ± 10.8	69	3	High
Seligman (43)	USA	Primary care clinics	Pre/post	HbA1c ≥ 6.5% or previously diagnosed diabetes	Yes	687	56.6	74	6	Critical
Bryce (26)	USA	Healthcare center	Pre/post	Diabetes mellitus and HbA1c >6.5%	No	65	52.5 ± 10.6	70.8	3.25	Serious
Cavanagh (27)	USA	Healthcare center	Retrospective case-control	Diabetes mellitus, BMI >30 kg/m2 and/or hypertension	No	108	NR	NR	18	Serious
Feinberg (34)	USA	Healthcare center	Pre/post	Diabetes mellitus and HbA1c > = 8%	Yes	95	NR	NR	18	Critical
Izumi (39)	USA	Healthcare center	Pre/post	None	No	9	NR	100	5.75	Serious
Trapl (40)	USA	Healthcare center	Pre/post	Hypertension	Yes	137	60.3 ± 10.9	71.1	6	Serious
Emmert-Aronson (41)	USA	Healthcare center	Pre/post	Diabetes mellitus, prediabetes, cardiac disease, hypertension, dyslipidemia, obesity, anxiety, and/or depression	Yes	49	59.1 ± 10.6	63.3	6	Serious
Forbes (25)	USA	Healthcare center	Pre/post	At risk of chronic illness or metabolic disease, as determined by primary care physicians	Yes	9	NR	55.6	1.5	Serious
Orsega-Smith (42)	USA	Pediatrician clinics	Pre/post	Overweight	Yes	41	NR	NR	12	Serious
Ferrer (44)	USA	Primary care clinic	RCT	HbA1c >9%	Yes	58	54	62	7	High

¹HbA1c, glycated hemoglobin; NR, not reported; RCT, randomized controlled trial; RoB, risk of bias.

²Values are mean ± SD.

³Detailed derivation of the overall risk of bias is provided in Supplemental Table 1.